InspireMD
NSPRInspireMD is a medical device company focused on developing and commercializing proprietary technologies for the treatment of carotid artery disease and other vascular conditions.
Earnings
Next report
Nov 10, 2026 (in 2 months)Competitors
By market cap
By revenue growth
Profile
InspireMD is a medical device company focused on developing and commercializing proprietary technologies for the treatment of carotid artery disease and other vascular conditions. Its core value proposition is the MicroNet mesh technology, a biocompatible sleeve designed to provide market-leading embolic protection by preventing plaque prolapse and debris release during and after stenting procedures. The company is strategically positioned to lead the clinical shift from open surgery to minimally invasive carotid revascularization.
InspireMD is a specialized challenger in the carotid stent market, leveraging its unique MicroNet technology to differentiate from traditional bare-metal stents produced by larger medical device conglomerates.
FAQ
- What is InspireMD's market cap?
- InspireMD (NSPR) has a market capitalization of $41.7M and trades on NASDAQ.
- Who are InspireMD's competitors?
- InspireMD's key competitors include Boston Scientific Corporation, Medtronic, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
- Who does InspireMD partner with?
- InspireMD's notable partners include Jacobs Institute, Aptyx Interventional Systems.
- Where is InspireMD headquartered?
- InspireMD is headquartered in Israel and employs approximately 66 people. It has been publicly traded since 1997.